3.2. The FD on the European Supervision Order............................................................... 52 3.2.1. Addressing the challenges related to pre-trial detention: The rationale behind the ESO.............................................................................................53 3.2.2. Practical Application of the ESO by EU Member States .....................................................54 3.2.3. Challenges regarding the practical application of the FD ESO ...........................................56 3.3. The Framework Decision on Probation and Alternative Sanctions.....................................58 3.4. Framework Decision on the Transfer of Prisoners .............................................................59 3.5. Framework Decisions on Detention as Chances for the Prevention of Ill-treatment: Conclusions and Recommendations ..................................................................................61 Conclusions.........................................................................................................................61 Recommendations .............................................................................................................62 PART TWO HOW STRENGTHENED ENGAGEMENT BETWEEN THE JUDICIARY AND NATIONAL PREVENTIVE MECHANISMS CAN CONTRIBUTE TO THE PREVENTION OF ILL-TREATMENT ................................ 63 Chapter 1. The role of judiciary and NPMs in the prevention of ill-treatment .............................................. 64 1.1. The role of the judiciary in the prevention of ill-treatment ...............................................64 1.2. The role of NPMs in the prevention of ill-treatment .........................................................65 1.3. NPMs and the judiciary – The benefits of engagement......................................................66 1.4. NPMs and Judiciary – the current status of engagement ..................................................68 Chapter 2. Methods and modes of engagement to contribute to the prevention of ill-treatment on a national level................................................................................................. 70 2.1. Issuing recommendations to the judiciary..........................................................................70 2.2. Institutional Exchange.........................................................................................................74 2.3. NPM contributions to court proceedings...........................................................................79 Chapter 3. Methods and modes of engagement that can contribute to the prevention of ill-treatment in cross-border proceedings........................................................................................................... 85 3.1. NPMs addressing the challenges of Framework Decisions on detention ..........................85 3.2. The potential in using NPM reports in cross-border transfer cases....................................86 3

Select target paragraph3